Analytical Data
-
Gene name
MPZL1
- Application
-
Alternative Names
MPZL1;PZR;Myelin Protein zero-like Protein 1
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O95297
-
Expression Region
38-162aa
-
AA Sequence
MGSSHHHHHH SSGLVPRGSH MGSLEVYTPK EIFVANGTQG KLTCKFKSTS TTGGLTSVSW SFQPEGADTT VSFFHYSQGQ VYLGNYPPFK DRISWAGDLD KKDASINIEN MQFIHNGTYI CDVKNPPDIV VQPGHIRLYV VEKENLPV
-
Molecular Weight
16 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MPZL1 (Myelin Protein Zero-Like 1) is a transmembrane protein that plays a crucial role in various biological processes, including cell adhesion, signaling, and immune response. Research has indicated that MPZL1 may be involved in the pathogenesis of several diseases, including cancers and autoimmune disorders, due to its influence on cell differentiation and migration. The exploration of MPZL1 recombinant protein has gained attention in recent years, particularly in understanding its structure-function relationship and potential therapeutic applications. By utilizing recombinant DNA technology, researchers can produce this protein in sufficient quantities to study its biochemical properties and interactions in vitro and in vivo. The characterization of MPZL1 is essential for uncovering its role in cellular mechanisms and its potential as a biomarker for disease diagnosis or target for therapeutic intervention. Advances in this field could lead to novel strategies for treating conditions that involve dysregulation of cell adhesion and signaling pathways, making the study of MPZL1 recombinant protein a promising area of biomedical research.
